Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Essential oils have been found to kill the deadly MRSA bacteria

Essential oils have been found to kill the deadly MRSA bacteria

Gene therapy effective in helping children with severe combined immunodeficiency (SCID)

Gene therapy effective in helping children with severe combined immunodeficiency (SCID)

FDA accepts Genmab's Investigational New Drug Application for active rheumatoid arthritis treatment

FDA accepts Genmab's Investigational New Drug Application for active rheumatoid arthritis treatment

Zarnestra, a farnesyl transferase inhibitor, can help treat high-risk myelodysplastic syndrome patients

Zarnestra, a farnesyl transferase inhibitor, can help treat high-risk myelodysplastic syndrome patients

Revlimid clinical data in newly diagnosed multiple myeloma presented

Revlimid clinical data in newly diagnosed multiple myeloma presented

Study shows long-term benefits for chronic myeloid leukemia patients receiving therapy with imatinib

Study shows long-term benefits for chronic myeloid leukemia patients receiving therapy with imatinib

New drug can successfully treat patients who have become resistant to Gleevec

New drug can successfully treat patients who have become resistant to Gleevec

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Researchers step closer to cure for common childhood cancer

Researchers step closer to cure for common childhood cancer

Genetic target found for pediatric leukemia

Genetic target found for pediatric leukemia

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome

A new treatment for patients with chronic myeloid leukemia

A new treatment for patients with chronic myeloid leukemia

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Data from phase II study of Trisenox (arsenic trioxide) injection in myelodysplasia

Single dose phase I data on CG53135 for the prevention of oral mucositis

Single dose phase I data on CG53135 for the prevention of oral mucositis

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

Oral targeted therapy shows benefit in treating high-risk myelodysplastic syndrome

Human endogenous retroviruses (HERVs)

Human endogenous retroviruses (HERVs)

Fossil record of the human immune system reveals antibodies that block cancer metastasis

Fossil record of the human immune system reveals antibodies that block cancer metastasis

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

Methylphenidate improves attention, behavior of children surviving acute lymphoblastic leukemia, brain tumors

Low level exposure to Benzene causes lower blood cell counts

Low level exposure to Benzene causes lower blood cell counts

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth